Form 4: MiniMed GC Converts Medtronic Awards to 55K MMED RSUs

MiniMed Group's General Counsel, Courtney Nelson Wills, converted over 55,000 Medtronic equity awards into MiniMed restricted stock units following the company's separation from Medtronic plc.

Summary

• Courtney Nelson Wills, Senior Vice President and General Counsel of MiniMed Group, Inc., acquired 55,063 Restricted Stock Units (RSUs) in MiniMed Group common stock.
• These acquisitions resulted from the conversion of previously held Medtronic plc restricted stock units and performance share units.
• The conversion is linked to MiniMed's separation from Medtronic plc, effective March 9, 2026.
• The conversion terms were established by the Employee Matters Agreement, dated March 1, 2026, between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc.
• The MMED RSUs were granted under the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP).
• The RSUs have various vesting dates: April 30, 2027 (18,082 and 955 units), April 28, 2028 (11,486 units), July 31, 2026 (5,151 units), July 29, 2027 (13,646 units), and July 28, 2028 (5,743 units).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a routine, non-discretionary conversion of executive equity awards following a corporate separation, aligning executive incentives with the new entity's performance.

Positives

• The conversion of Medtronic awards into MiniMed RSUs aligns the executive's long-term incentives directly with MiniMed Group's performance post-separation.
• The grant of RSUs under the 2026 MiniMed Group, Inc. Long Term Incentive Plan indicates a structured approach to executive compensation and retention.

Negatives

• No direct negatives are apparent from this Form 4 filing, which primarily reports a non-discretionary equity conversion event.

Future Outlook

The filing indicates a structured approach to executive compensation post-separation, with long-term incentives tied to MiniMed Group's equity performance through the 2026 MiniMed Group, Inc. Long Term Incentive Plan.

Industry Context

StockSavvy.ai notes that this Form 4 filing reflects a standard procedure following a corporate spin-off or separation, where equity awards from the parent company are converted into awards of the newly independent entity. This ensures continuity of executive compensation and aligns management incentives with the performance of the new company, MiniMed Group, Inc., post-Medtronic separation. Such conversions are critical for retaining key talent and maintaining stable corporate governance during transitional periods.

Comparison to Industry Standards

• The conversion of equity awards during a corporate separation, such as a spin-off, is a common practice across industries to ensure executive compensation continuity and alignment with the new entity's performance.
• For example, when PayPal separated from eBay in 2015, or when Hewlett Packard Enterprise spun off from HP Inc. in 2015, similar conversions of employee stock options and restricted stock units occurred to reflect the new corporate structures.
• The use of a Long Term Incentive Plan (LTIP) for the newly granted RSUs is standard for publicly traded companies, comparable to plans at major medical technology firms like Abbott Laboratories or Boston Scientific, which use similar equity-based compensation to incentivize long-term performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The conversion aligns executive incentives with the long-term performance of MiniMed Group, potentially benefiting shareholders through motivated leadership.
• Employees: The establishment of the 2026 MiniMed Group, Inc. Long Term Incentive Plan provides a framework for equity compensation, which can be a tool for employee retention and motivation.

Next Steps

• Continued vesting of the granted MMED RSUs on their respective schedules: July 31, 2026, April 30, 2027, July 29, 2027, April 28, 2028, and July 28, 2028.

Key Dates

Recommendation

This Form 4 filing reports a non-discretionary conversion of equity awards for a key executive following a corporate separation. It is a routine administrative event that aligns executive incentives with the new company's performance and does not provide new information warranting a change in investment thesis. Investors should 'hold' and focus on MiniMed Group's operational performance and strategic direction post-separation.

Keywords

MiniMed Group, MMED, Medtronic, SEC Form 4, Restricted Stock Units, RSUs, Equity Conversion, Insider Transaction, Executive Compensation, Separation, Spin-off, Long Term Incentive Plan